“Are CRT upgrade procedures more complex and associated with more complications than de novo CRT implantations?” A single centre experience
نویسندگان
چکیده
OBJECTIVE The objective of the study was to examine whether cardiac resynchronisation therapy upgrade procedures are more complex and associated with more complications than de novo implantations. METHOD We retrospectively compared 134 upgrade procedures performed between 2006-2012 with a random, equally sized, sample of de novo CRT device implantations in the same period. Procedural data and the occurrence of periprocedural (≤ 30 days) and long-term device-related (≤ 1 year) complications were analysed. Complications with consequences were defined as those in need of adjustment of standard care. RESULTS Median time to upgrade was 57 (31-115) months. There were no significant differences in procedure duration, radiation time or total hospitalisation between upgrades and de novo implantations. Perioperative complications occurred in 6.7 % of upgrade patients and in 9.0 % of de novo patients. The most frequently seen complications were phrenic nerve stimulation, coronary sinus dissection and pocket haematoma. Procedure success was comparable (upgrade: 98.5 % versus de novo: 96.3 %). A total of 236 patients completed 1 year of follow-up. Ten (4.2 %) patients had a long-term device-related complication with consequences including phrenic nerve stimulation, lead dislodgement/dysfunction, and infection (upgrade: 3.5 % versus de novo: 4.9 %). CONCLUSION Upgrade procedures are not more complex nor associated with more complications than de novo CRT implantations.
منابع مشابه
Effects of Upgrade Versus De Novo Cardiac Resynchronization Therapy on Clinical Response and Long-Term Survival: Results from a Multicenter Study.
BACKGROUND Benefits of cardiac resynchronization therapy (CRT) on morbidity and mortality in selected patients are well known. Although the number of upgrade procedures from single- or dual-chamber devices to CRT is increasing, there are only sparse data on the outcomes of upgrade procedures compared with de novo CRT. This study aimed to evaluate clinical response and survival in patients recei...
متن کاملEffects of Upgrade Versus De Novo Cardiac Resynchronization Therapy on Clinical Response and Long-Term Survival
The beneficial impact of newly implanted cardiac resynchronization therapy (CRT) on morbidity and mortality are well described in selected patients with heart failure. Patients with heart failure already fitted with a conventional pacemaker or implantable cardioverter defibrillator (ICD) system are often considered for a CRT upgrade after the new development of CRT criteria (ie, new left bundle...
متن کاملSuccess rate of transvenous left ventricular lead implantation for cardiac resynchronisation therapy - recent experience of a single centre.
BACKGROUND Implantation of a left ventricular (LV) lead for cardiac resynchronisation therapy (CRT) may be challenging. Wider use of various implantation techniques increases the success rate of CRT. AIM Short-term analysis of the success rate of transvenous LV lead implantation for CRT. METHODS All CRT procedures performed in 2009 with first-time LV lead implantation attempt were analysed ...
متن کاملComparison of De Novo versus Upgrade Cardiac Resynchronization Therapy; Focused on the Upgrade for Pacing-Induced Cardiomyopathy
PURPOSE This study aimed to determine whether upgrade cardiac resynchronization therapy (CRT) shows better outcomes than de novo CRT. To do so, we compared the efficacy of CRT between de novo and upgrade groups, focusing particularly on the effect of upgrade CRT on patients with pacing-induced cardiomyopathy (PiCM). MATERIALS AND METHODS PiCM was defined as new-onset dilated cardiomyopathy fo...
متن کاملIncidence, predictors, and procedural results of upgrade to resynchronization therapy: the RAFT upgrade substudy.
BACKGROUND The resynchronization-defibrillation for ambulatory heart failure trial (RAFT) study demonstrated that adding cardiac resynchronization therapy (CRT) in selected patients requiring de novo implantable cardiac defibrillators (ICD) reduced mortality as compared with ICD therapy alone, despite an increase in procedure-related adverse events. Data are lacking regarding the management of ...
متن کامل